Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

13.27
Delayed Data
As of Feb 17
 -0.03 / -0.23%
Today’s Change
10.80
Today|||52-Week Range
45.20
-12.06%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close13.30
Today’s open13.25
Day’s range13.12 - 13.43
Volume437,362
Average volume (3 months)612,692
Market cap$574.2M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)+2.27%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.70+0.85%
VSARVersartis Inc+0.65+4.14%
ACHNAchillion Pharmaceut...0.000.00%
ESPREsperion Therapeutic...+1.81+7.81%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts


Search for Jobs